| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| ACCOUNTING FEES | 1,970 | 0 | 0 |
| Name | Date Acquired | How Acquired | Date Sold | Purchaser Name | Gross Sales Price | Basis | Basis Method | Sales Expenses | Total (net) | Accumulated Depreciation |
|---|---|---|---|---|---|---|---|---|---|---|
| ARENA PHARMACEUTICALS INC COM NEW | 2013-02 | PURCHASED | 2021-12 | 3,208 | 2,813 | COST | 0 | 395 | ||
| ARENA PHARMACEUTICALS INC COM NEW | 2013-02 | PURCHASED | 2021-12 | 1,649 | 1,447 | COST | 0 | 202 | ||
| ARENA PHARMACEUTICALS INC COM NEW | 2014-05 | PURCHASED | 2021-12 | 27,205 | 20,785 | COST | 0 | 6,420 | ||
| ARENA PHARMACEUTICALS INC COM NEW | 2014-05 | PURCHASED | 2021-12 | 13,740 | 9,768 | COST | 0 | 3,972 | ||
| SANGAMO THERAPEUTICS INC COM | 2015-04 | PURCHASED | 2021-01 | 3,094 | 2,656 | COST | 0 | 438 | ||
| SANGAMO THERAPEUTICS INC COM | 2015-04 | PURCHASED | 2021-01 | 7,735 | 6,620 | COST | 0 | 1,115 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| ARENA PHARMACEUTICAL S INC - 2400 SHS | 130,982 | 223,056 |
| SANGAMO BIOSCIENCES INC - 800 SHS | 10,592 | 6,000 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| FORM PC STATE FILING FEE | 35 | 0 | 0 | |
| MARGIN INTEREST | 160 | 0 | 0 |